Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion-Burden Patients With Lower-Risk Myelodysplastic Syndromes in a Phase II Study
|
Oct 2020
|
Journal of clinical oncology: official journal of the American Society Clinical Oncology
|
myelodysplastic syndromes (MDS)
|
Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion-Burden Patients With Lower-Risk Myelodysplastic Syndromes in a Phase II Study
|
Jan 2020
|
Journal of clinical oncology: official journal of the American Society Clinical Oncology
|
myelodysplastic syndromes (MDS)
|
Eprenetapopt (APR-246) and Azacitidine in TP53-Mutant Myelodysplastic Syndromes
|
Jan 2021
|
Journal of clinical oncology: official journal of the American Society Clinical Oncology
|
myelodysplastic syndromes (MDS)
|
Eprenetapopt Plus Azacitidine in TP53-Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Phase II Study by the Groupe Francophone des Myélodysplasies (GFM)
|
Feb 2021
|
Journal of clinical oncology: official journal of the American Society Clinical Oncology
|
myelodysplastic syndromes (MDS)
|
Parsing the Paradox of Myelodysplastic Syndromes
|
Dec 2020
|
Journal of clinical oncology: official journal of the American Society Clinical Oncologysd
|
myelodysplastic syndromes (MDS)
|
Whole-genome sequencing identifies novel predictors for hematopoietic cell transplant outcomes for patients with myelodysplastic syndrome: a CIBMTR study
|
Apr 2023
|
Journal of Hematology & Oncology
|
myelodysplastic syndromes (MDS)
|
T Cell Transcriptomes from Paroxysmal Nocturnal Hemoglobinuria Patients Reveal Novel Signaling Pathways
|
Jul 2017
|
Journal of Immunology
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
Paroxysmal nocturnal hemoglobinuria: patient journey and burden of disease
|
Dec 2020
|
Journal of Managed care and specialty pharmacy
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
Paroxysmal nocturnal hemoglobinuria: role of the complement system, pathogenesis, and pathophysiology
|
Dec 2020
|
Journal of Managed care and specialty pharmacy
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
Paroxysmal nocturnal hemoglobinuria: current treatments and unmet needs
|
Dec 2020
|
Journal of Managed care and specialty pharmacy
|
paroxysmal nocturnal hemoglobinuria (PNH)
|